Product Details
Additional Information
| Product Name | Adenosine Vl |
| Manufacturer Name | APP Pharm |
| MFG # | 17478-0542-02 |
| Concentration | 3 mg/mL |
| Volume | 2 mL |
| Packaging | 10 Vials / Box |
| Dosage | As prescribed by healthcare professional |
| Usage | For intravenous use |
| Application | Pharmaceutical |
| Seal | Single-use vial, must be discarded after use |
Description
Adenosine VL, available in 3mg/ml concentration and packaged in 2ml vials, is a medication commonly used in medical settings. This sterile solution is administered intravenously and is utilized for its antiarrhythmic properties, particularly in the treatment of supraventricular tachycardia (SVT). The vials are constructed from high-quality glass, ensuring the integrity and safety of the medication during storage and administration. Each vial features a secure closure to prevent leakage and maintain sterility.
With its precise concentration and convenient packaging, Adenosine VL offers healthcare professionals an effective and reliable solution for managing cardiac arrhythmias. The clear labeling on the vials provides easy identification of the medication, facilitating efficient workflow in busy clinical environments. The compact size of the vials makes them easy to handle and store, optimizing space in medical supply cabinets and crash carts. Adenosine VL is an essential component of emergency medical kits and cardiac care units, where rapid intervention is crucial for patient outcomes.
Product Properties:
| Description | N |
|---|---|
| Description | N |
| Description | Adenosine inj, 1 MG |
| DESI Drug Ind | - |
| DESI Drug Ind | $4.64; 01/01/2017 |
| DESI Drug Ind | $4.64; 01/01/2017 |
| DESI2 Drug Ind | - |
| Drug Category | N |
| Drug Type Code | 1 |
| FDA Approval Date | 10/31/2008 |
| FDA Therap Equiv | AP |
| HCPCS | 1 |
| HCPCS | J0153 |
| HCPCS | 1 |
| Market Entry Date | 03/14/2011 |
| Medical Coverage | COVERED WITH SPECIAL INSTRUCTIONS |
| Medical Coverage | - |
| Medical Coverage | - |
| Termination Date | - |
| Unit | ML |
| Units Per Pkg | 2 |
| Active Ingredients | 3603 adenosine 58617 |
| Active Ingredients | 3603 adenosine 58617 |
| Active Ingredients | 3603 adenosine 58617 |
| AHFS Class | 24040424 CLASS IV ANTIARRHYTHMICS; 24040400 ANTIARRHYTHMIC AGENTS |
| AHFS Class | 24040424 CLASS IV ANTIARRHYTHMICS; 24040400 ANTIARRHYTHMIC AGENTS |
| AHFS Class | 24040424 CLASS IV ANTIARRHYTHMICS; 24040400 ANTIARRHYTHMIC AGENTS |
| DEA Class | NC |
| DEA Class | NC |
| DEA Class | NC |
| Dose Form | VIAL (ML) |
| Dose Form | VIAL (ML) |
| Dose Form | VIAL (ML) |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 13630 adenosine INTRAVEN VIAL 3 MG/ML |
| Gen Code and Des | 13630 adenosine INTRAVEN VIAL 3 MG/ML |
| Gen Code and Des | 13630 adenosine INTRAVEN VIAL 3 MG/ML |
| Inactive Ingredients | - |
| Inactive Ingredients | - |
| Inactive Ingredients | - |
| OMP Family | - |
| OMP Family | - |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Strength | 6MG |
| Strength | 6MG |
| Strength | 6MG |
| Common Brand Name | J0153 |
| Common Brand Name | J0153 |
| Drug Interaction | - |
| Drug Interaction | - |
| Allocation Period | - |
| Allocation Period | - |
| Allocation Period | - |
| Case Quantity | 24 |
| Case Quantity | 24 |
| Case Quantity | 24 |
| Drug Form Pack Size | 20 |
| Drug Form Pack Size | 20 |
| Drug Form Pack Size | 20 |
| Form | SINGLE DOSE VIAL |
| Form | SINGLE DOSE VIAL |
| Form | SINGLE DOSE VIAL |
| Hazard Code | - |
| Hazard Code | - |
| Hazard Code | - |
| Listed Chemical | - |
| Listed Chemical | - |
| Listed Chemical | - |
| NIOSH Code | - |
| NIOSH Code | - |
| NIOSH Code | - |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Returnable Status | Not Returnable |
| Returnable Status | Not Returnable |
| Returnable Status | Not Returnable |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit | EA |
| Unit | EA |
| Unit Size | 10X2 |
| Unit Size | 10X2 |
| Unit Size | 10X2 |
| How to Use | - |
| How to Use | - |
| Missed Dose | 2 |
| Missed Dose | 2 |
| Notes | ML |
| Notes | ML |
| Overdose | AP |
| Overdose | AP |
| Phonetic Pronunciation | COVERED WITH SPECIAL INSTRUCTIONS |
| Phonetic Pronunciation | COVERED WITH SPECIAL INSTRUCTIONS |
| Precautions | - |
| Precautions | - |
| Side Effects | - |
| Side Effects | - |
| Storage | 10/31/2008 |
| Storage | 10/31/2008 |
| Uses | Adenosine inj, 1 MG |
| Uses | Adenosine inj, 1 MG |
Frequently Asked Questions (FAQs)
The cost of ADENOSINE 6 MG SDV 10X2 ML is $available for registerd members only
ADENOSINE 6 MG SDV 10X2 ML is manufactured by Akorn.
You can purchase ADENOSINE 6 MG SDV 10X2 ML on our website at https://supplies.pipelinemedical.com/product/detail/adenosine-6-mg-sdv-10x2-ml-315016